孟鲁司特钠治疗小儿喘息性支气管炎患儿的临床效果

The Clinical Effect of Montelukast Sodium in the Treatment of Children with Asthmatic Bronchitis

目的探讨孟鲁司特钠治疗小儿喘息性支气管炎患儿的临床效果。方法选取2013年4月至2014年4月医院收治的50例小儿喘息性支气管炎患儿作为研究对象,并将其随机均分成对照组和试验组。两组均给予常规治疗,试验组在常规治疗基础上给予孟鲁司特钠药物治疗。观察并比较两组临床治疗效果。结果试验组临床治疗效果明显优于对照组,住院时间和喘息症状缓解时间均比对照组短;随访发现试验组喘息发生次数、症状消失时间明显低于对照组,差异有统计学意义(P<0.05)。结论孟鲁斯特钠在小儿喘息性支气管炎患儿治疗中具有显著的临床疗效,值得临床推广。

Objective To investigate the clinical effect of montelukast sodium in the treatment of children with asthmatic bronchitis. Methods 50 children with asthmatic bronchitis in the hospital were selected as the research object from April 2013 to April 2014, and they were randomly divided into control group and experimental group. Two groups were given conventional treatment and the experimental group was given montelukQst sodium treatment on the basis of conventional treatment. The clinical therapeutic effect of the two groups Was observed and compared. Results The clinical therapeutic effect of experimental group was significant better than control group. The length of stay and wheezing symptoms of experimental group were less than control group. The number of wheezing and symptoms disappearance time of experimental group were significant lower than control group after follow-up, the differences between two groups had statistical significance （P〈0.05）. Conclusion Montelukast sodium has significant clinical efficacy in the treatment of children with asthmatic bronchitis, which is wodhy of clinical promotion.